APA (7th ed.) Citation

Yu, Q., Wang, Y., Ungchusri, E., Patel, M., Kumari, D., Ha, T. V., . . . Ahmed, O. (2023). Combination of transarterial radioembolization with atezolizumab and bevacizumab for intermediate and advanced staged hepatocellular carcinoma: A preliminary report of safety and feasibility. KeAi Communications Co., Ltd.

Chicago Style (17th ed.) Citation

Yu, Qian, Yating Wang, Ethan Ungchusri, Mikin Patel, Divya Kumari, Thuong Van Ha, Anjana Pillai, Chih-yi Liao, and Osman Ahmed. Combination of Transarterial Radioembolization with Atezolizumab and Bevacizumab for Intermediate and Advanced Staged Hepatocellular Carcinoma: A Preliminary Report of Safety and Feasibility. KeAi Communications Co., Ltd, 2023.

MLA (9th ed.) Citation

Yu, Qian, et al. Combination of Transarterial Radioembolization with Atezolizumab and Bevacizumab for Intermediate and Advanced Staged Hepatocellular Carcinoma: A Preliminary Report of Safety and Feasibility. KeAi Communications Co., Ltd, 2023.